Shi Wenjie, Torres-de la Roche Luz Angela, Ritter Henning, Dong Jie, Zeng Jia-Jia, Jiang Yi-Cheng, Zhuo Rui, De Wilde Rudy Leon
University Hospital for Gynecology, Pius-Hospital, University Medicine Oldenburg, 26121, Oldenburg, Germany.
Director Sino-European Brest Care Nurse School in Guilin, PR China.
Ann Med Surg (Lond). 2021 Jul 17;68:102576. doi: 10.1016/j.amsu.2021.102576. eCollection 2021 Aug.
Insufficient glandular tissue in the lower quadrant of the breast is the main source of difficulty in repairing defects after oncoplastic surgery. Especially in small to medium sized breasts, this issue is more common. Here, we describe a novel oncoplastic approach that could help to solve this problem.
Retrospective analysis of breast cancer patients with tumors in the lower inner quadrants, who underwent Zhuo's technique between January 2017 and August 2019. Aesthetic outcomes were evaluated in terms of the Paris Breast Center's 5-point scale. The work was reported according to the STROCSS criteria.
Nine patients (mean age 54 years) with small to medium volume breast received Zhuo's oncoplastic technique after tumor excision. The mean size tumor was 18.0 mm. The median follow-up time was 27.0 months. Sentinel lymph node biopsy results for all patients were negative. None of the patients had local recurrences or metastases and postoperative complications were not observed. Seven patients (77.8%) achieved aesthetic scores of 5 and two patients (22.2%) achieved 4 points.
Zhuo's oncoplastic technique could provide a favorable and flexible surgical approach for small to medium volume breast with tumors of the lower inner quadrant with a low risk of recurrence and good aesthetic results.
Chinese clinical trial register No. ChiCTR2100043484.
乳腺下象限腺体组织不足是肿瘤整形手术后修复缺损困难的主要原因。特别是在中小尺寸乳房中,这个问题更为常见。在此,我们描述一种可有助于解决该问题的新型肿瘤整形方法。
回顾性分析2017年1月至2019年8月间接受卓氏技术治疗的乳房内下象限肿瘤乳腺癌患者。根据巴黎乳腺中心的5分制评估美学效果。本研究按照STROCSS标准报告。
9例(平均年龄54岁)中小体积乳房患者在肿瘤切除后接受了卓氏肿瘤整形技术。肿瘤平均大小为18.0mm。中位随访时间为27.0个月。所有患者前哨淋巴结活检结果均为阴性。无一例患者出现局部复发或转移,未观察到术后并发症。7例(77.8%)患者美学评分为5分,2例(22.2%)患者评分为4分。
卓氏肿瘤整形技术可为乳房内下象限有肿瘤的中小体积乳房提供一种有利且灵活的手术方法,复发风险低,美学效果良好。
中国临床试验注册中心编号ChiCTR2100043484